A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

Completed · Phase 4 · Has a placebo group

Conditions studied: Upper Respiratory Infections

In brief

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.

Key facts

Study ID

NCT02225912

Run by

BioHealth Technologies Inc.

Starts

2005-02-01

Expected to finish

2005-05-01

Last updated by the study team

2019-01-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must provide written informed consent prior to the conduct of any study
• Male or female
• 18-65 years of age
• Inclusive
• Employed by one of seven selected Day Care Centers

You may not qualify if…

• Recent symptoms of upper respiratory infection, respiratory disease
• Received medication for colds or allergies within 3 weeks of enrolling
• Had nasal surgery within 2 months of enrolling
• Had a pierced nose or wore nose jewelry

Where it is running

• Sunflower Preschool & Day Care — Hialeah, Florida, United States
• Sunflower Preschool Childcare — Miami, Florida, United States
• Sunflowers Academy — Miami, Florida, United States
• Sunflowers Academy — Miami, Florida, United States
• Sunflowers Preschool Childcare — Miami, Florida, United States
• Mt Sinai Day Care — Miami Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.